These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32677086)

  • 21. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
    Li Q; Zhu X; Song W; Peng X; Zhao R
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
    de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
    Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells.
    Asatryan L; Ostrovskaya O; Lieu D; Davies DL
    Neuropharmacology; 2018 Jan; 128():11-21. PubMed ID: 28943285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of P2X7 antagonists with a focus on CNS indications.
    Rech JC; Bhattacharya A; Letavic MA; Savall BM
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis.
    Ruiz-Ruiz C; Calzaferri F; García AG
    Front Mol Neurosci; 2020; 13():93. PubMed ID: 32595451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7-NMDA Receptor Antagonists.
    Karoutzou O; Kwak SH; Lee SD; Martínez-Falguera D; Sureda FX; Vázquez S; Kim YC; Barniol-Xicota M
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29361735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.
    Zheng H; Liu Q; Zhou S; Luo H; Zhang W
    Front Immunol; 2024; 15():1345625. PubMed ID: 38370420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease.
    Bianchi C; Alvarez-Castelao B; Sebastián-Serrano Á; Di Lauro C; Soria-Tobar L; Nicke A; Engel T; Díaz-Hernández M
    Alzheimers Res Ther; 2023 Jun; 15(1):105. PubMed ID: 37287063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease.
    Chen YH; Lin RR; Tao QQ
    Life Sci; 2021 Apr; 271():119187. PubMed ID: 33577858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
    Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
    J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From lead to clinic: A review of the structural design of P2X7R antagonists.
    Zhang R; Li N; Zhao M; Tang M; Jiang X; Cai X; Ye N; Su K; Peng J; Zhang X; Wu W; Ye H
    Eur J Med Chem; 2023 May; 251():115234. PubMed ID: 36893624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.
    Vergani A; Tezza S; D'Addio F; Fotino C; Liu K; Niewczas M; Bassi R; Molano RD; Kleffel S; Petrelli A; Soleti A; Ammirati E; Frigerio M; Visner G; Grassi F; Ferrero ME; Corradi D; Abdi R; Ricordi C; Sayegh MH; Pileggi A; Fiorina P
    Circulation; 2013 Jan; 127(4):463-75. PubMed ID: 23250993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Possible Causal Involvement of Neuroinflammatory, Purinergic P2X7 Receptors in Psychiatric Disorders.
    Zhang Y; Yin HY; Rubini P; Tang Y; Illes P
    Curr Neuropharmacol; 2022; 20(11):2142-2155. PubMed ID: 35236262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state.
    Ahn YH; Tang Y; Illes P
    Expert Opin Ther Targets; 2023; 27(9):763-778. PubMed ID: 37712394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons.
    Chen Y; Zhang X; Wang C; Li G; Gu Y; Huang LY
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16773-8. PubMed ID: 18946042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The P2X7 receptor: A main player in inflammation.
    Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
    Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonists, Antagonists, and Modulators of P2X7 Receptors.
    Müller CE; Namasivayam V
    Methods Mol Biol; 2022; 2510():31-52. PubMed ID: 35776318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models.
    Fischer W; Franke H; Krügel U; Müller H; Dinkel K; Lord B; Letavic MA; Henshall DC; Engel T
    PLoS One; 2016; 11(6):e0156468. PubMed ID: 27281030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice.
    Domingos LB; Hott SC; Terzian ALB; Resstel LBM
    Neuropharmacology; 2018 Jan; 128():474-481. PubMed ID: 28802645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.